StudyTeam
Connected platform enabling clinical trial stakeholders to collaborate on enrollment and trial management
Company profile
Company profile
Reify Health is a clinical trials technology and operations company founded with the mission to remove clinical trial operations as the bottleneck on delivering new therapies to patients. For over a decade, the company has focused on innovation across the clinical trial lifecycle, from patient access to trial execution and logistics coordination. The company operates two main initiatives: Care Access, which builds research sites and partnerships with communities to expand clinical trial access in underserved areas, and OneStudyTeam (formerly StudyTeam), a technology platform that connects research sites, sponsors, patients, and other stakeholders on a common workflow system. The OneStudyTeam platform addresses the historical problem of clinical trial stakeholders working in silos by enabling real-time collaboration, visibility, and coordination. The platform initially focused on clinical trial enrollment, helping sites pre-screen and enroll patients while giving sponsors unprecedented real-time visibility into enrollment progress. Reify Health's approach combines technology innovation with operational expertise gained from systematically building new research sites. The company serves sponsors, research sites, and ultimately patients by creating a connected technology foundation that integrates seamlessly with other solutions and makes clinical research more integral to healthcare delivery. As a parent company, Reify Health oversees both Care Access and OneStudyTeam, and is a founding member of the BRIDGE Initiative.
Company description Reify Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Company milestones
September 2022: Rebranded StudyTeam business unit to OneStudyTeam to reflect broader vision of connecting all clinical trial stakeholders. Care Access and OneStudyTeam continue operating as businesses within Reify Health parent company.
Partnerships
No partners are currently listed.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Connected platform enabling clinical trial stakeholders to collaborate on enrollment and trial management
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Current cardiology reports · Oct 1, 2023
Biologic Therapy Is Not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Updated Findings from the Global Hidradenitis Suppurativa COVID-19 Registry.Dermatology (Basel, Switzerland) · Jan 1, 2023
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Sponsors gain unprecedented real-time clarity into trial enrollment progress
Sites save time keeping sponsors informed about trial enrollment
Bringing new-to-research physicians and practices in underserved communities into the clinical trial ecosystem
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Reify Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.